论文部分内容阅读
为考查准分子激光屈光性角膜切削术（ＰＲＫ）治疗近视眼的临床效果，作者对该院经治，并有三个月随访资料的１４５例进行了总结。结果：该组患者术前屈光度为－１．５～－１１．５Ｄ，裸眼视力有１３７例在０．１以下占９４％，０．５以下８例占６％。术后一个月时裸眼视力在１．０及１．０以上者占６６％，有９８％的患者裸眼视力达到０．５以上，平均屈光度为＋０．９８±０．８８Ｄ。术后三个月时有７２％的患者裸眼视力在１．０及１．０以上，９３％的患者裸眼视力恢复到０．５以上，平均屈光度为－０．１３±１．０９Ｄ。全组患者均无严重并发症发生，表明ＰＲＫ手术是一种有效、安全和预测性较好的治疗近视眼方法。
To examine the clinical efficacy of excimer laser refractive keratectomy (PRK) in the treatment of myopia, the authors summarized the hospital’s treatment of 145 cases with three-month follow-up data. Results: The preoperative refraction of this group was -1.5 ~ -11.5D, 137 cases of uncorrected visual acuity were 94% under 0.1, 8 cases accounted for 6% under 0.5. One month after surgery, the uncorrected visual acuity was above 1.0% and 1.0% in 66%. The visual acuity of uncorrected visual acuity was above 0.5 in 98% of patients and the average refractive power was + 0.98 ± 0.88D. Visual acuity of the uncorrected eyes was above 1.0 and 1.0 in 72% of the patients at 3 months after operation. Visual acuity of the uncorrected eyes returned to above 0.5 in 93% of the patients, and the average refractive power was -0.13 ± 1.09D. No serious complications occurred in all patients, indicating that PRK surgery is an effective, safe and predictive method for the treatment of myopia.